Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
October 2011
Features
Pharmaceutical Approval Update
Vemurafenib (Zelboraf) for metastatic melanoma, brentuximab vedotin (Adcetris) for Hodgkin’s lymphoma and anaplastic large-cell lymphoma, and icatibant (Firazyr) for acute attacks of hereditary angioedema
Marvin M. Goldenberg, PhD, RPh, MS
Health Care and Law
The Medication-Use Process and the Importance of Mastering Fundamentals
Medication errors often occur because pharmacists are not following the basic principles of prescription filling. In this month’s column, the authors discuss the importance of training, maintaining concentration during the dispensing process, and focusing on the “five rights” to improve safety for patients.
F. Randy Vogenberg, RPh, PhD; and David Benjamin, PhD
Influenza Update
A Review of Currently Available Vaccines
Nine influenza vaccines are currently on the market. The author discusses the various types and dosage forms along with CDC recommendations and considerations for special populations.
Lisa R. Clayville, PharmD
Direct-to-Consumer Pharmaceutical Advertising
Therapeutic or Toxic?
The FDA regulates DTC pharmaceutical advertising, but critics say that the rules are too relaxed and inadequately enforced. Although there have been calls to ban the ads altogether, remedies to maximize the benefits and minimize the risks have also been proposed.
C. Lee Ventola, MS
Commentary
Pharmacists Want a More Explicit Role in ACOs
Medicare’s Hands Are Tied ... at Least Initially
Given the fact that pharmacists already account for significant health care cost savings, there has been a lot of unhappiness about their omission from the ACO experiment.
Stephen Barlas
Departments
Medication Errors
Avoiding Problems With Insulin Pens In the Hospital
Avoiding problems with insulin pen injectors in the hospital
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Supreme Court to Rule on Medicaid Cuts to Health Care Providers
California Pharmacists Initiate Lawsuits
The Supreme Court must decide whether pharmacists can challenge state laws, pre-empting federal law, that have reduced Medicaid payments to health care providers.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Drug Forecast
Azilsartan Medoxomil (Edarbi)
The Eighth Angiotensin II Receptor Blocker
Azilsartan medoxomil (Edarbi), the eighth angiotensin II receptor blocker for hypertension
Jocelyn D. Jones, PharmD, BCPS; Sylvia H. Jackson, PharmD, MEd, CDE; Carmen Agboton, PharmD; and Tonya S. Martin, PharmD, CGP, MAEd
